Consun Pharmaceutical Group
Consun Pharmaceutical Group (HKEX: 1681) is a healthcare company transforming modern Chinese medicine heritage into globally relevant small-molecule and biologic innovations. With nephrology as its flagship specialty, Consun delivers a diversified product portfolio spanning chronic kidney disease therapies, imaging diagnostics, women’s & children’s health, orthopedics, dermatology, and hepatobiliary care. In 2024, the Group achieved RMB 2.97 billion (USD 417 million) in revenue, up 14.6 % year-on-year, and generated RMB 0.91 billion (USD 127.7 million) in net profit attributable to shareholders, marking 16.1 % growth. We strive to advance healthcare, create shared value for stakeholders, and improve quality of life for patients worldwide.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1001 to 5000
headcount range
Open roles
—
no listings
Distinct roles
0
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Consun Pharmaceutical Group
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Sign up to unlock all 1 contacts at Consun Pharmaceutical Group
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Consun Pharmaceutical Group
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.